NYSE · REIT - Healthcare Facilities · USD
Ventas, Inc. (VTR) Stock Analysis
Ventas, Inc. (VTR) is a REIT - Healthcare Facilities stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
VTR Key Statistics
As of Sep 4, 2026Trading
- Open
- $91.32
- Previous Close
- $92.11
- Day's Range
- 90.15–92.22
- 52-Week Range
- 66.54–101.60
- Volume
- 3.50M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.72
Valuation
- Market Cap
- $46.30B
- P/E Ratio
- 164.13
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 114.27
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.72
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 7.21
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.55
Financials (FY)
- Revenue (FY)
- $5.83B+18.47%
- Net Income (FY)
- $251.38M+209.76%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 4.09%
- Shares Outstanding
- 512.95M
- 1-Year Return
- +36.71%
Dividend and dates
- Dividend
- $2.08+2.26%
- Ex-Dividend Date
- June 30, 2026
- Earnings Date
- October 28, 2026
- Avg Volume
- 3.58M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
VTR Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +18.09% |
| 2025 | +35.09% |
| 2024 | +22.24% |
| 2023 | +15.06% |
| 2022 | −8.53% |
| 2021 | +7.73% |
| 2020 | −9.80% |
| 2019 | +3.43% |
| 2018 | +3.45% |
| 2017 | +0.71% |
| 2016 (partial year) | −11.89% |
As of September 4, 2026.
VTR Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $5.83B | $251.38M | 4.3% |
| 2024 | $4.92B | $81.15M | 1.6% |
| 2023 | $4.50B | −$40.97M | −0.9% |
| 2022 | $4.13B | −$47.45M | −1.1% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $5.83B | $2.41B | $857.52M | $251.38M | 4.3% |
| 2024 | $4.92B | $2.10B | $681.23M | $81.15M | 1.6% |
| 2023 | $4.50B | $1.94B | $415.51M | −$40.97M | −0.9% |
| 2022 | $4.13B | $1.85B | $483.85M | −$47.45M | −1.1% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
VTR Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.04 | 2 | — |
| 2025 | $1.92 | 4 | +6.7% |
| 2024 | $1.80 | 4 | +0.0% |
| 2023 | $1.80 | 4 | +0.0% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.04 | 2 | — |
| 2025 | $1.92 | 4 | +6.7% |
| 2024 | $1.80 | 4 | +0.0% |
| 2023 | $1.80 | 4 | +0.0% |
| 2022 | $1.80 | 4 | +0.0% |
| 2021 | $1.80 | 4 | −16.0% |
| 2020 | $2.14 | 4 | −32.4% |
| 2019 | $3.17 | 4 | +0.3% |
| 2018 | $3.16 | 4 | +1.5% |
| 2017 | $3.12 | 4 | +107.0% |
| 2016 | $1.51 | 2 | — |
Most recent payment: $0.52 per share, ex-dividend June 30, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
VTR Valuation vs REIT - Healthcare Facilities Median
Median of 21 stocks| Metric | VTR | REIT - Healthcare Facilities median | vs median |
|---|---|---|---|
| P/E | 164.13 | 27.03 | 6.1x the median |
| P/S ratio | 7.21 | 5.78 | 25% above |
| Profit margin | 4.09% | 7.58% | 3.5 pts below |
Medians across 21 REIT - Healthcare Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Ventas (VTR) is a Top Dividend Stock Right Now: Should You Buy?
YahooScotiabank Maintains Sector Perform on Ventas, Raises Price Target to $95
BenzingaWells Fargo Maintains Overweight on Ventas, Raises Price Target to $104
BenzingaBarclays Maintains Equal-Weight on Ventas, Raises Price Target to $102
BenzingaVentas (VTR) Up 1.1% Since Last Earnings Report: Can It Continue?
YahooVentas (NYSE:VTR) Shows a Strong Technical Breakout Setup With Perfect Trend Strength
ChartMill
All 20 articles ↓Show fewer ↑
Ventas (VTR) Could Be a Great Choice
YahooVentas Releases 2025-2026 Corporate Sustainability Report
YahooVentas (VTR) Stock Looks Reasonable Even With Mixed Value Signals
YahooRBC Capital Maintains Outperform on Ventas, Raises Price Target to $99
BenzingaBMO Capital Maintains Outperform on Ventas, Raises Price Target to $107
BenzingaAre Wall Street Analysts Bullish on Ventas Stock?
YahooVentas (VTR) Q2 2026 Earnings Call Transcript
YahooVentas Q2 Earnings Call Highlights
YahooCantor Fitzgerald Maintains Overweight on Ventas, Raises Price Target to $102
BenzingaVentas Inc (VTR) (Q2 2026) Earnings Call Highlights: Record NOI Growth and Raised Guidance ...
YahooVentas Q2 FFO & Revenues Beat Estimates on Strong SHOP Growth
YahooVentas, Inc. (VTR) Q2 2026 Earnings Call Transcript
SeekingAlphaVentas, Inc. 2026 Q2 - Results - Earnings Call Presentation
SeekingAlphaVentas (VTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related REIT - Healthcare Facilities Stocks
Welltower Inc.
$170.18B
OHIOmega Healthcare Investors, Inc.
$14.81B
DOCHealthpeak Properties, Inc.
$14.64B
AHRAmerican Healthcare REIT, Inc.
$11.93B
CTRECareTrust REIT, Inc.
$9.22B
HRHealthcare Realty Trust Incorporated
$6.63B
Popular Real Estate Stocks
Prologis, Inc.
$133.51B
EQIXEquinix, Inc.
$102.22B
AMTAmerican Tower Corporation
$81.94B
SPGSimon Property Group, Inc.
$79.51B
DLRDigital Realty Trust, Inc.
$71.15B













